AACR and FDA Introduce New Fellowship Program
A new fellowship program is giving 20 early-career researchers a window into oncology drug development and the regulatory review...
Category: AACR
A new fellowship program is giving 20 early-career researchers a window into oncology drug development and the regulatory review...
As we enter the winter holiday season, it’s time for the latest edition of Editors’ Picks, our monthly staple...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a grim prognosis. While early-stage PDAC may be removed by...
With coronavirus infections on the rise, we all feel the strain of the pandemic. The stress has deepened for those who are caring for people who are...
Breast cancer is the most common cancer among women in the United States and worldwide, with an estimated 2.1 million women diagnosed each year....
In June 2020, the American Association for Cancer Research (AACR) hosted the second class of Global Scholar-In-Training Awardees (GSITA) during...
The screen goes blue, that unmistakable tune starts playing, and the voice of Johnny Gilbert announces, “This. Is. Jeopardy!” We meet the contestants. We hear...
In 2019, Michael D. Story, PhD, vice chair of the Department of Radiation Oncology and chief of the Division of Molecular Radiation Biology at UT Southwestern Medical Center, was one of...
For September, the editors of the nine AACR journals have chosen to highlight a clinical trial that evaluated an Hsp90 inhibitor for...
Every September 24, World Cancer Research Day provides an opportunity to raise awareness about the important role research plays...